I am Mutthuraj Dasegowda, a PhD researcher in Molecular Oncology and Epigenetics at Division of Molecular Biology, JSS Academy of Higher Education & Research, Mysuru, India. My work bridges molecular oncology, epigenetics, and bioactive natural products, currently investigating the anti-cancer properties of Moringa oleifera in epithelial ovarian cancer through integrated molecular and cellular approaches. My interests span cancer biology, molecular docking, nanomedicine, phytochemical therapeutics, and precision oncology, focusing on signaling pathways driving cancer progression and drug resistance. I have contributed to peer-reviewed articles, reviews, and book chapters on oncology and medicinal plants, and hold two Government of India design patents for preclinical instruments: a Hot Plate Analgesiometer and an Apparatus for Estimation of Plasma Drug Concentration. I received the Junior Research Fellowship from JSS AHER, plus young researcher honors.
Citations: 45 | h-index: 3 | i10-index: 2 (Scholar/Scopus/ResearchGate, July 2026)
I am Mutthuraj Dasegowda, a PhD researcher in Molecular Oncology and Epigenetics at Division of Molecular Biology, JSS Academy of Higher Education & Research, Mysuru, India. My work bridges molecular oncology, epigenetics, and bioactive natural products, currently investigating the anti-cancer properties of Moringa oleifera in epithelial ovarian cancer through integrated molecular and cellular approaches. My interests span cancer biology, molecular docking, nanomedicine, phytochemical therapeutics, and precision oncology, focusing on signaling pathways driving cancer progression and drug resistance. I have contributed to peer-reviewed articles, reviews, and book chapters on oncology and medicinal plants, and hold two Government of India design patents for preclinical instruments: a Hot Plate Analgesiometer and an Apparatus for Estimation of Plasma Drug Concentration. I received the Junior Research Fellowship from JSS AHER, plus young researcher honors.
Citations: 45 | h-index: 3 | i10-index: 2 (Scholar/Scopus/ResearchGate, July 2026)